CDX2 Transcription Factor
"CDX2 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antennapedia-like homeodomain transcription factor that regulates the expression of multiple genes in the INTESTINAL MUCOSA. It plays a critical role in many processes from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine.
| Descriptor ID |
D000071616
|
| MeSH Number(s) |
D12.776.260.400.140 D12.776.660.201 D12.776.930.146
|
| Concept/Terms |
CDX2 Transcription Factor- CDX2 Transcription Factor
- Homeobox Protein CDX-2
- CDX-2, Homeobox Protein
- Homeobox Protein CDX 2
- Homeobox Protein CDX2
- CDX2, Homeobox Protein
- Caudal Type Homeo Box Transcription Factor 2
- Caudal Type Homeo Box 2 Protein
- Transcription Factor CDX2
- CDX2, Transcription Factor
- Cdx-2 Protein
- Cdx 2 Protein
- Cdx-3 Protein
- Cdx 3 Protein
- Cdx-2-3 Protein
- Cdx 2 3 Protein
- CDX2 Protein
- Caudal Type Homeobox Transcription Factor 2
|
Below are MeSH descriptors whose meaning is more general than "CDX2 Transcription Factor".
Below are MeSH descriptors whose meaning is more specific than "CDX2 Transcription Factor".
This graph shows the total number of publications written about "CDX2 Transcription Factor" by people in this website by year, and whether "CDX2 Transcription Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CDX2 Transcription Factor" by people in Profiles.
-
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. Blood. 2022 06 16; 139(24):3519-3531.
-
Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Hum Pathol. 2022 07; 125:35-47.
-
Immunohistochemical Expression of CDX2 and SATB2 in Primary Breast Carcinomas. Appl Immunohistochem Mol Morphol. 2020 07; 28(6):e53.
-
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer. Br J Cancer. 2019 10; 121(7):593-599.
-
Degree of Tissue Differentiation Dictates Susceptibility to BRAF-Driven Colorectal Cancer. Cell Rep. 2017 12 26; 21(13):3833-3845.
-
Aspirin prevents NF-?B activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus. Gut. 2018 04; 67(4):606-615.
-
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer. 2015 Jun 30; 113(1):64-8.
-
Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation. PLoS One. 2013; 8(9):e74556.
-
Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset. Int J Clin Oncol. 2014; 19(3):479-84.
-
SOX2 redirects the developmental fate of the intestinal epithelium toward a premature gastric phenotype. J Mol Cell Biol. 2012 Dec; 4(6):377-85.